Covid-19 roundup: Daiichi's mRNA shot enters the clinic; South Africa sells its AstraZeneca supply to neighbors
Another mRNA-based vaccine is entering the clinic.
Over a year after Moderna kicked off trials for their mRNA-based Covid-19 shot, Japanese drugmaker Daiichi-Sankyo announced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
